Regulatory and effector T-cells are differentially modulated by Dexamethasone

Clinical Immunology

Volumn 149, Issue 3 PB, 2013, Pages 400-410

  Pandolfi, Julieta ^a   Baz, Plácida ^a   Fernández, Pablo ^a   Discianni Lupi, Ailén ^a   Payaslián, Florencia ^a   Billordo, Luis Ariel ^a   Fainboim, Leonardo ^a   Arruvito, Lourdes ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Apoptosis; Cytokines; Effector T cells; Glucocorticoids; Regulatory T cells

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MIFEPRISTONE; PROTEIN BAX; TRANSCRIPTION FACTOR FOXP3;

ADULT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL VIABILITY; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HELA CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; T LYMPHOCYTE SUBPOPULATION; TURNOVER TIME; UTERINE CERVIX CANCER;

EID: 84887135381     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.09.008     Document Type: Article

References (54)

1. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., Parizot C., Taflin C., Heike T., Valeyre D., Mathian A., Nakahata T., Yamaguchi T., Nomura T., Ono M., Amoura Z., Gorochov G., Sakaguchi S. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
2. Arruvito L., Sabatte J., Pandolfi J., Baz P., Billordo L.A., Lasala M.B., Salomon H., Geffner J., Fainboim L. Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients. PLoS One 2012, 7:e52580.
3. Refojo D., Liberman A.C., Holsboer F., Arzt E. Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids. Immunol. Cell Biol. 2001, 79:385-394.
4. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 2005, 353:1711-1723.
5. Ashwell J.D., Lu F.W., Vacchio M.S. Glucocorticoids in T cell development and function*. Annu. Rev. Immunol. 2000, 18:309-345.
6. Paliogianni F., Ahuja S.S., Balow J.P., Balow J.E., Boumpas D.T. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 1993, 151:4081-4089.
7. Almawi W.Y., Beyhum H.N., Rahme A.A., Rieder M.J. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 1996, 60:563-572.
8. Vanderheyde N., Verhasselt V., Goldman M., Willems F. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999, 67:1342-1347.
9. Stary G., Klein I., Bauer W., Koszik F., Reininger B., Kohlhofer S., Gruber K., Skvara H., Jung T., Stingl G. Glucocorticosteroids modify Langerhans cells to produce TGF-beta and expand regulatory T cells. J. Immunol. 2011, 186:103-112.
10. Chen X., Murakami T., Oppenheim J.J., Howard O.M. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to Dexamethasone-induced cell death. Eur. J. Immunol. 2004, 34:859-869.
11. Chen X., Oppenheim J.J., Winkler-Pickett R.T., Ortaldo J.R., Howard O.M. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 2006, 36:2139-2149.
12. Stock P., Akbari O., DeKruyff R.H., Umetsu D.T. Respiratory tolerance is inhibited by the administration of corticosteroids. J. Immunol. 2005, 175:7380-7387.
13. Wust S., van den Brandt J., Tischner D., Kleiman A., Tuckermann J.P., Gold R., Luhder F., Reichardt H.M. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J. Immunol. 2008, 180:8434-8443.
14. Karagiannidis C., Akdis M., Holopainen P., Woolley N.J., Hense G., Ruckert B., Mantel P.Y., Menz G., Akdis C.A., Blaser K., Schmidt-Weber C.B. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 2004, 114:1425-1433.
15. Azab N.A., Bassyouni I.H., Emad Y., Abd El-Wahab G.A., Hamdy G., Mashahit M.A. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin. Immunol. 2008, 127:151-157.
16. Xystrakis E., Kusumakar S., Boswell S., Peek E., Urry Z., Richards D.F., Adikibi T., Pridgeon C., Dallman M., Loke T.K., Robinson D.S., Barrat F.J., O'Garra A., Lavender P., Lee T.H., Corrigan C., Hawrylowicz C.M. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 2006, 116:146-155.
17. Braitch M., Harikrishnan S., Robins R.A., Nichols C., Fahey A.J., Showe L., Constantinescu C.S. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol. Scand. 2009, 119:239-245.
18. Banica L., Besliu A., Pistol G., Stavaru C., Ionescu R., Forsea A.M., Tanaseanu C., Dumitrache S., Otelea D., Tamsulea I., Tanaseanu S., Chitonu C., Paraschiv S., Balteanu M., Stefanescu M., Matache C. Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 2009, 42:41-49.
19. Majak P., Rychlik B., Stelmach I. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clin. Exp. Allergy 2009, 39:1830-1841.
20. Zhang B., Zhang X., Tang F., Zhu L., Liu Y. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 2008, 153:182-187.
21. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., Clayberger C., Soper D.M., Ziegler S.F., Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006, 203:1701-1711.
22. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., Kelleher A., Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006, 203:1693-1700.
23. Yolcu E.S., Ash S., Kaminitz A., Sagiv Y., Askenasy N., Yarkoni S. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol. Cell Biol. 2008, 86:650-658.
24. Arruvito L., Sanz M., Banham A.H., Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 2007, 178:2572-2578.
25. Jaleco S., Swainson L., Dardalhon V., Burjanadze M., Kinet S., Taylor N. Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J. Immunol. 2003, 171:61-68.
26. Yarkoni S., Kaminitz A., Sagiv Y., Yaniv I., Askenasy N. Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle. Bioessays 2008, 30:875-888.
27. Fritzsching B., Oberle N., Eberhardt N., Quick S., Haas J., Wildemann B., Krammer P.H., Suri-Payer E. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand - but not to TCR-mediated cell death. J. Immunol. 2005, 175:32-36.
28. Nelson B.H. IL-2, regulatory T cells, and tolerance. J. Immunol. 2004, 172:3983-3988.
29. Malek T.R., Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 2004, 4:665-674.
30. Goleva E., Kisich K.O., Leung D.Y. A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J. Immunol. 2002, 169:5934-5940.
31. Creed T.J., Lee R.W., Newcomb P.V., di Mambro A.J., Raju M., Dayan C.M. The effects of cytokines on suppression of lymphocyte proliferation by Dexamethasone. J. Immunol. 2009, 183:164-171.
32. Arzt E., Kovalovsky D., Igaz L.M., Costas M., Plazas P., Refojo D., Paez-Pereda M., Reul J.M., Stalla G., Holsboer F. Functional cross-talk among cytokines, T-cell receptor, and glucocorticoid receptor transcriptional activity and action. Ann. N. Y. Acad. Sci. 2000, 917:672-677.
33. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., Piccirillo C.A., Salomon B.L., Bluestone J.A. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008, 28:687-697.
34. Gillis S., Smith K.A. Long term culture of tumour-specific cytotoxic T cells. Nature 1977, 268:154-156.
35. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
36. Strasser A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 2005, 5:189-200.
37. Wojciechowski S., Tripathi P., Bourdeau T., Acero L., Grimes H.L., Katz J.D., Finkelman F.D., Hildeman D.A. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J. Exp. Med. 2007, 204:1665-1675.
38. Deng G., Podack E.R. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:2189-2193.
39. Wang X., Szymczak-Workman A.L., Gravano D.M., Workman C.J., Green D.R., Vignali D.A. Preferential control of induced regulatory T cell homeostasis via a Bim/Bcl-2 axis. Cell Death Dis. 2012, 3:e270.
40. Goleva E., Li L.B., Leung D.Y. IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance. Am. J. Respir. Cell Mol. Biol. 2009, 40:223-230.
41. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001, 167:1245-1253.
42. Levings M.K., Sangregorio R., Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001, 193:1295-1302.
43. Taams L.S., Vukmanovic-Stejic M., Smith J., Dunne P.J., Fletcher J.M., Plunkett F.J., Ebeling S.B., Lombardi G., Rustin M.H., Bijlsma J.W., Lafeber F.P., Salmon M., Akbar A.N. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur. J. Immunol. 2002, 32:1621-1630.
44. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001, 193:1285-1294.
45. Baecher-Allan C., Viglietta V., Hafler D.A. Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J. Immunol. 2002, 169:6210-6217.
46. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
47. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M., Byrne M.C. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002, 16:311-323.
48. Seissler N., Schmitt E., Hug F., Sommerer C., Zeier M., Schaier M., Steinborn A. Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patients. Transpl. Immunol. 2012, 27:157-161.
49. Unger W.W., Laban S., Kleijwegt F.S., van der Slik A.R., Roep B.O. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or Dexamethasone: differential role for PD-L1. Eur. J. Immunol. 2009, 39:3147-3159.
50. Tai X., Erman B., Alag A., Mu J., Kimura M., Katz G., Guinter T., McCaughtry T., Etzensperger R., Feigenbaum L., Singer D.S., Singer A. Foxp3 Transcription Factor Is Proapoptotic and Lethal to Developing Regulatory T Cells unless Counterbalanced by Cytokine Survival Signals. Immunity 2013, 38:1116-1128.
51. Marchetti D., Van N.T., Gametchu B., Thompson E.B., Kobayashi Y., Watanabe F., Barlogie B. Flow cytometric analysis of glucocorticoid receptor using monoclonal antibody and fluoresceinated ligand probes. Cancer Res. 1989, 49:863-869.
52. Liu X., Yang P., Lin X., Ren X., Zhou H., Huang X., Chi W., Kijlstra A., Chen L. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clin. Immunol. 2009, 131:333-342.
53. Sharabi A., Haviv A., Zinger H., Dayan M., Mozes E. Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to Dexamethasone: different effects on cytokines and apoptosis. Clin. Immunol. 2006, 119:146-155.
54. Sbiera S., Dexneit T., Reichardt S.D., Michel K.D., van den Brandt J., Schmull S., Kraus L., Beyer M., Mlynski R., Wortmann S., Allolio B., Reichardt H.M., Fassnacht M. Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS One 2011, 6:e24345.